You are browsing content specific to your location, some treatments may not be available:

+971 2 652 8000

Dr. Barbara Lawrenz
Dr. Barbara Lawrenz
Specialist Reproductive Medicine and Infertility

Scientific Director, ART Fertility Clinics

Dr. Barbara Lawrenz obtained her Medical Degree from Germany in 1989 and completed her specialization in Gynecology and Obstetrics in 1995. In 2004, she also gained expertise in Obstetrics and Prenatal Medicine followed by Gynecological Endocrinology and Reproductive Medicine. Dr. Lawrenz is an expert in fertility preservation before cytotoxic therapy in women with malignant diseases and fertility preservation for those undergoing cancer treatment and cancer survivors. She has authored/co-authored  65 pub-med reviewed articles in international journals and additional articles in various prestigious German journals. Dr. Lawrenz was the Head of the IVF Department at Women's University Hospital Tubingen, Germany, and is an esteemed member of the European Society of Human Reproduction (ESHRE).

English
German
Abu Dhabi, UAE

Experience

  • IVF Specialist, Abu Dhabi, UAE
  • Head of IVF department, Women´s University Hospital Tübingen, Germany
  • Senior Physician in Gynecology and Obstetrics, Women´s University Hospital Tübingen, Germany
  • Senior Physician in Gynecology and Obstetrics, General Hospital of Sindelfingen, Germany
  • Senior Physician in Gynecology and Obstetrics, General Hospital of Speyer, Germany
  • Residency in Gynecology and Obstetrics, General Hospital of Reutlingen, Germany
Dr. Barbara Lawrenz
  • Global Clinical Scholars Research Training (GCSRT) Certificate Program, Harvard Medical School. Boston, USA, 2020-2021.
  • Habilitation thesis: Fertility preservation before cytotoxic therapy in young girls, adolescents, and premenopausal women. Obtaining the designation lecturer ("Privatdozentin") Teaching license of the University of Tübingen for Obstetrics and Gynecology
  • Certificate for University Teaching and Learning in Medicine
  • Specialization in gynecological endocrinology and reproductive medicine
  • Specialization in obstetrics and perinatal medicine
  • Specialist in gynecology and obstetrics
  • Doctoral dissertation: "Determination of Protein C with capillary methods" Grade: "cum laude”
  • Study of medicine in Berlin and Giessen, Germany

•    Anti-müllerian Hormone During Natural Cycle Presents Significant Intra and Intercycle Variations When Measured With Fully Automated Assay
•    Inter-assay variation and reproducibility of progesterone measurements during ovarian stimulation for IVF
•    The effects of cancer therapy on women’s fertility: what do we know now?
•    Clinical reassessment of human embryo ploidy status between cleavage and blastocyst stage by Next Generation Sequencing
•    Is the ovarian reserve influenced by vitamin D deficiency and the dress code in an infertile Iranian population?
•    Impact of stimulation duration and gonadotropin type on the incidence of premature progesterone elevation – a retrospective analysis of the Ensure data
•    Luteal phase serum progesterone levels after GnRH-agonist trigger - how low is still high enough for an ongoing pregnancy?
•    Premature progesterone elevation: targets and rescue strategies
•    Anti-müllerian hormone variability during ovarian stimulation for IVF: A novel approach to predict fertility treatment outcomes
•    Luteal Coasting and Individualization of Human Chorionic Gonadotropin Dose after Gonadotropin-Releasing Hormone Agonist Triggering for Final Oocyte Maturation—A Retrospective Proof-of-Concept Study
•    Premature progesterone rise in ART-cycles
•    What Drives Embryo Development? Chromosomal Normality or Mitochondria?
•    Individual luteolysis pattern after GnRH agonist trigger for final oocyte maturation
•    Effect of progesterone elevation in follicular phase of IVF-cycles on the endometrial receptivity
•    Individual luteolysis post GnRH-agonist-trigger in GnRH-antagonist protocols
•    Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles
•    Absence of luteal phase defect and spontaneous pregnancy in IVF patients despite GnRH-agonist trigger and “freeze all policy" without luteal phase support: a report of four cases
•    A non -receptive ERA test result in an HRT cycle may not be replicable in a natural cycle: A case report
•    Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
•    Isthmocele and ovarian stimulation for IVF: considerations for a reproductive medicine specialist
•    Reply: Careful and expert interpretation of PGT-A data can resolve the mosaicism dilemma
•    Significant Serum Progesterone Variations on the Day of Final Oocyte Maturation in Stimulated IVF Cycles
•    The importance of embryo quality and day of biopsy in frozen single euploid blastocyst transfer cycles
•    Anti-Müllerian Hormone as a Quantitative and Qualitative Marker of Euploid Blastocysts.
•    ESHRE 2019: The Depth of Embryo Replacement Inside the Uterine Cavity Influences Pregnancy and Implantation Rates in IVF
•    Is There A Relationship Between Mitochondrial DNA Content And Abortion Rate In Patients Undergoing Single Euploid Frozen Embryo Transfer?
•    Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study.
•    IS PARENTAL CONSANGUINITY ASSOCIATED WITH LOW OVARIAN RESERVE AND HIGHER RATE OF ANEUPLOIDIES?
•    Mitochondrial DNA content of cleavage stage embryos and their relation to preimplantation development and aneuploidy
•    Cleavage stage mitochondrial DNA is correlated with preimplantation human embryo development and ploidy status
•    mtDNA dynamics between cleavage-stage embryos and blastocysts
•    The clinicians ́ dilemma with mosaicism—an insight from inner cell mass biopsies
•    Anti-Müllerian Hormone (AMH) as a quantitative and qualitative marker of euploid blastocysts.
•    Anti-Müllerian Hormone (AMH) is an independent marker for oocyte survival post vitrification.
•    Individualized luteal phase support
•    A non -receptive ERA test result in an HRT cycle may notbe replicable in a natural cycle: A case report
•    Ethnical and sociocultural differences causing infertility are poorly understood—insights from the Arabian perspective
•    Inhibin A—A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI
•    Is a naturally reduced antimullerian hormone at a young age linked to an increased risk of cancer development?
•    Blastocyst mitochondrial DNA (mtDNA) is not affected by oocyte vitrification: a sibling oocyte study
•    ANTI-MULLERIAN HORMONE IS AN INDEPENDENT MARKER FOR OOCYTE SURVIVAL POST-VITRIFICATION
•    The ART of frozen embryo transfer: back to nature!
•    The search must go on - for patients with recurrent pregnancy loss
•    Intracytoplasmic sperm injection is not superior to conventional IVF in couples with non-male factor infertility and preimplantation genetic testing for aneuploidies (PGT-A)
•    Vitamin D in Follicular Fluid Correlates With the Euploid Status of Blastocysts in a Vitamin D Deficient Population Does blastocyst mitochondrial DNA content affect miscarriage rate in patients undergoing single euploid frozen embryo transfer?Gibt es optimale Serumprogesteronwerte in In-vitro-Fertilisations- und Kryozyklen?

Fertility
Personalized Luteal Phase Support
WATCH NOW
Abu Dhabi
Fertility
Fertility Preservation
WATCH NOW
Abu Dhabi

Note: Doctor's schedule is subject to change, Please contact the clinic for more information

See our Doctors & Experts at Abu Dhabi